Tatva Chintan Pharma Chem Limited (TATVA) — Cash Flow Quality Index
Tatva Chintan Pharma Chem Limited (TATVA) has a Cash Flow Quality Index of 3.81x as of December 2023. Operating cash flow of Rs131.66 Million exceeds net income of Rs34.55 Million, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of Tatva Chintan Pharma Chem Limited to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tatva Chintan Pharma Chem Limited Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Tatva Chintan Pharma Chem Limited across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Tatva Chintan Pharma Chem Limited.
Annual Cash Flow Quality Index for Tatva Chintan Pharma Chem Limited (2018–2025)
Year-by-year earnings quality comparison for Tatva Chintan Pharma Chem Limited.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.32x | Rs246.71 Million | Rs57.13 Million | ▲ +33.7% |
| 2024 | 3.23x | Rs980.44 Million | Rs303.54 Million | ▲ +420.6% |
| 2023 | 0.62x | Rs277.83 Million | Rs447.79 Million | ▲ +217.0% |
| 2022 | 0.20x | Rs203.78 Million | Rs1.04 Billion | ▼ -51.2% |
| 2021 | 0.40x | Rs243.19 Million | Rs606.96 Million | ▼ -24.7% |
| 2020 | 0.53x | Rs253.12 Million | Rs475.97 Million | ▲ +98.0% |
| 2019 | 0.27x | Rs73.56 Million | Rs273.93 Million | ▼ -68.3% |
| 2018 | 0.85x | Rs104.12 Million | Rs122.89 Million | — |